Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      S‐adenosyl methionine‐AMP opens another skylight of CRISPR system: discovering novel second messenger for bacterial antiviral immunity

      research-article
      1 , , 1 , 2 , 3 ,
      MedComm
      John Wiley and Sons Inc.
      antiviral, CRISPR, second messenger

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references5

          • Record: found
          • Abstract: found
          • Article: not found

          Systematic discovery of antiphage defense systems in the microbial pangenome

          The arms race between bacteria and phages led to the development of sophisticated antiphage defense systems, including CRISPR-Cas and restriction-modification systems. Evidence suggests that unknown defense systems are located in "defense islands" in microbial genomes. We comprehensively characterized the bacterial defensive arsenal by examining gene families that are clustered next to known defense genes in prokaryotic genomes. Candidate defense systems were systematically engineered and validated in model bacteria for their antiphage activities. We report nine previously unknown antiphage systems and one antiplasmid system that are widespread in microbes and strongly protect against foreign invaders. These include systems that adopted components of the bacterial flagella and condensin complexes. Our data also suggest a common, ancient ancestry of innate immunity components shared between animals, plants, and bacteria.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Phage anti-CBASS and anti-Pycsar nucleases subvert bacterial immunity

            The cyclic oligonucleotide-based antiphage signalling system (CBASS) and the pyrimidine cyclase system for antiphage resistance (Pycsar) are antiphage defence systems in diverse bacteria that use cyclic nucleotide signals to induce cell death and prevent viral propagation 1,2 . Phages use several strategies to defeat host CRISPR and restriction-modification systems 3–10 , but no mechanisms are known to evade CBASS and Pycsar immunity. Here we show that phages encode anti-CBASS (Acb) and anti-Pycsar (Apyc) proteins that counteract defence by specifically degrading cyclic nucleotide signals that activate host immunity. Using a biochemical screen of 57 phages in Escherichia coli and Bacillus subtilis, we discover Acb1 from phage T4 and Apyc1 from phage SBSphiJ as founding members of distinct families of immune evasion proteins. Crystal structures of Acb1 in complex with 3′3′-cyclic GMP–AMP define a mechanism of metal-independent hydrolysis 3′ of adenosine bases, enabling broad recognition and degradation of cyclic dinucleotide and trinucleotide CBASS signals. Structures of Apyc1 reveal a metal-dependent cyclic NMP phosphodiesterase that uses relaxed specificity to target Pycsar cyclic pyrimidine mononucleotide signals. We show that Acb1 and Apyc1 block downstream effector activation and protect from CBASS and Pycsar defence in vivo. Active Acb1 and Apyc1 enzymes are conserved in phylogenetically diverse phages, demonstrating that cleavage of host cyclic nucleotide signals is a key strategy of immune evasion in phage biology.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              RNA-targeting CRISPR–Cas systems

                Bookmark

                Author and article information

                Contributors
                huangyongye88@163.com , huangyongye@mail.neu.edu.cn
                minwoo2022@126.com
                Journal
                MedComm (2020)
                MedComm (2020)
                10.1002/(ISSN)2688-2663
                MCO2
                MedComm
                John Wiley and Sons Inc. (Hoboken )
                2688-2663
                27 April 2024
                May 2024
                : 5
                : 5 ( doiID: 10.1002/mco2.v5.5 )
                : e522
                Affiliations
                [ 1 ] Key Laboratory of Bioresource Research and Development of Liaoning Province College of Life and Health Sciences Northeastern University Shenyang China
                [ 2 ] Wenzhou Traditional Chinese Medicine Hospital of Zhejiang Chinese Medical University Wenzhou China
                [ 3 ] Wenzhou Institute University of Chinese Academy of Sciences Wenzhou Zhejiang China
                Author notes
                [*] [* ] Correspondence

                Yongye Huang, Key Laboratory of Bioresource Research and Development of Liaoning Province, College of Life and Health Sciences, Northeastern University, Shenyang 110169, China.

                Email: huangyongye88@ 123456163.com , huangyongye@ 123456mail.neu.edu.cn

                Min Wu, Wenzhou Traditional Chinese Medicine Hospital of Zhejiang Chinese Medical University, Wenzhou 325000, China.

                Email: minwoo2022@ 123456126.com

                Article
                MCO2522
                10.1002/mco2.522
                11055957
                38680519
                c8fc4204-45e8-4628-9f8d-fb4da645c5fd
                © 2024 The Authors. MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 26 February 2024
                : 30 November 2023
                : 07 March 2024
                Page count
                Figures: 1, Tables: 0, Pages: 4, Words: 1736
                Funding
                Funded by: National Natural Science Foundation of China , doi 10.13039/501100001809;
                Award ID: 81502582
                Funded by: Fundamental Scientific Research Fund of Liaoning Provincial Education Department
                Award ID: LJKQZ2021002
                Funded by: Construction Project of Liaoning Provincial Key Laboratory, China
                Award ID: 2022JH13/10200026
                Categories
                Highlights
                Highlights
                Custom metadata
                2.0
                May 2024
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.4.0 mode:remove_FC converted:28.04.2024

                antiviral,crispr,second messenger
                antiviral, crispr, second messenger

                Comments

                Comment on this article